James Scherschel
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, Alzheimer's disease research and treatments, Gene expression and cancer classification, Genomics and Phylogenetic Studies
Most-Cited Works
- → BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders(2015)135 cited
- → Investigating the neuroimmunogenic architecture of schizophrenia(2017)70 cited
- → A human tau seeded neuronal cell model recapitulates molecular responses associated with Alzheimer’s disease(2022)14 cited
- → Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b(2023)5 cited
- → TractaViewer: a genome-wide tool for preliminary assessment of therapeutic target druggability(2019)5 cited
- → Modeling heat flow in a thermos(2003)5 cited
- Modeling heat flow in a thermos : an honors thesis (HONRS 499)(2000)
- DE NOVO TRANSCRIPTION FACTOR BINDING SITE DISCOVERY: A MACHINE LEARNING AND MODEL SELECTION APPROACH(2009)
- → Additional file 2 of Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b(2023)
- → Additional file 3 of Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b(2023)